Source:http://linkedlifedata.com/resource/pubmed/id/20218623
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2010-6-3
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1520-4804
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
10
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4332-53
|
pubmed:meshHeading | |
pubmed:year |
2010
|
pubmed:articleTitle |
Emerging targets in osteoporosis disease modification.
|
pubmed:affiliation |
Chemistry Research and Discovery, Amgen, Inc., One Amgen Center Drive, Thousand Oaks, California 91320, USA. johallen@amgen.com
|
pubmed:publicationType |
Journal Article,
Review
|